의약품 안전성 정보
본문
최신약물정보 (FDA 승인 약물 2013.6-2013.8)
- · 작성 : 최희영
- · 작성일 2014-02-03 17:16
Brisdelle (low-dose paroxetine mesylate) Noven Pharmaceuticals; For the treatment of vasomotor symptoms of menopause, Approved July 2013
Mirvaso (brimonidine) Galderma Labs; For the treatment of facial erythema of rosacea, Approved August 2013
Brisdelle (low-dose paroxetine mesylate) Noven Pharmaceuticals; For the treatment of vasomotor symptoms of menopause, Approved July 2013
Fetzima (levomilnacipran) Forest Labs; For the treatment of major depressive disorder, Approved July 2013